CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
+40.86%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
(+22%)
Cap. Flow
-$4.3M
Cap. Flow
% of AUM
-4.2%
Top 10 Holdings %
Top 10 Hldgs %
44.11%
Holding
78
New
16
Increased
26
Reduced
11
Closed
5
Top Buys
| 1 |
ARKO Corp
ARKO
|
$1.43M |
| 2 |
CVS Health
CVS
|
$1.38M |
| 3 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$1.07M |
| 4 |
B
Barrick Mining Corporation
B
|
$847K |
| 5 |
Talos Energy
TALO
|
$832K |
Top Sells
| 1 |
Elicio Therapeutics
ELTX
|
$6.99M |
| 2 |
NeueHealth
NEUE
|
$5.79M |
| 3 |
Preformed Line Products
PLPC
|
$1.64M |
| 4 |
OneSpan
OSPN
|
$1.23M |
| 5 |
TAST
Carrols Restaurant Group, Inc.
TAST
|
$882K |
Sector Composition
| 1 | Healthcare | 42% |
| 2 | Industrials | 9.41% |
| 3 | Energy | 9.38% |
| 4 | Financials | 8.51% |
| 5 | Consumer Discretionary | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
1
DELISTED
Immunogen Inc
IMGN
| $9.44M | 9.2% | 500,000 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $5.65M | 5.51% | 450,000 | – | – |
|
3
Alico
ALCO
$259M
| $5.47M | 5.34% | 215,000 | – | – |
|
4
National Healthcare
NHC
$1.76B
| $4.64M | 4.52% | 75,000 | – | – |
|
5
Radiant Logistics
RLGT
$305M
| $4.03M | 3.93% | 600,000 +40,000 | +7% | +$269K |
|
|
TGB
6
Taseko Mines
TGB
$1.03B
| $3.58M | 3.49% | 2,500,000 | – | – |
|
7
Ark Restaurants
ARKR
$24.6M
| $3.42M | 3.33% | 184,607 | – | – |
|
|
8
Talos Energy
TALO
$1.73B
| $3.12M | 3.04% | 225,000 +60,000 | +36% | +$832K |
|
|
SWN
9
DELISTED
Southwestern Energy Company
SWN
| $3.01M | 2.93% | 500,000 | – | – |
|
10
BGC Group
BGC
$4.65B
| $2.88M | 2.81% | 650,000 | – | – |
|
|
11
Preformed Line Products
PLPC
$941M
| $2.73M | 2.66% | 17,500 -10,500 | -38% | -$1.64M |
|
12
DURECT Corp
DRRX
$59.6M
| $2.33M | 2.27% | 470,000 +70,000 | +18% | +$347K |
|
|
TAST
13
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $2.27M | 2.21% | 450,000 -175,000 | -28% | -$882K |
|
14
American Superconductor
AMSC
$2.25B
| $2.19M | 2.14% | 350,000 | – | – |
|
15
Newmark Group
NMRK
$3.22B
| $2.18M | 2.12% | 350,000 +25,000 | +8% | +$156K |
|
|
16
ARKO Corp
ARKO
$564M
| $2.11M | 2.06% | 590,000 +400,000 | +211% | +$1.43M |
|
17
Rigel Pharmaceuticals
RIGL
$697M
| $1.94M | 1.89% | 1,500,000 | – | – |
|
|
18
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $1.92M | 1.87% | 450,000 +250,000 | +125% | +$1.07M |
|
19
Fidelity National Financial
FNF
$16.3B
| $1.8M | 1.76% | 50,000 +20,000 | +67% | +$720K |
|
20
Cytosorbents Corp
CTSO
$59.2M
| $1.62M | 1.58% | 450,000 | – | – |
|
21
Brookline Bancorp
BRKL
$976M
| $1.57M | 1.53% | 180,000 +55,000 | +44% | +$481K |
|
|
22
CVS Health
CVS
$92.8B
| $1.38M | 1.35% | +20,000 | New | +$1.38M |
|
23
Fidelity National Information Services
FIS
$36.5B
| $1.37M | 1.33% | 25,000 +5,000 | +25% | +$274K |
|
24
Kyndryl
KD
$7.35B
| $1.33M | 1.3% | 100,000 +40,000 | +67% | +$531K |
|
25
ClearPoint Neuro
CLPT
$298M
| $1.3M | 1.27% | 180,000 +5,000 | +3% | +$36.2K |
|